Novartis psoriasis drug, Cosentyx, receives FDA approval
The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis. PsoriasisPublic domain image/Bodiadub Psoriasis is a skin condition that causes More...